A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 268
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DPB
Long Form : diffuse panbronchiolitis
No. Year Title Co-occurring Abbreviation
2019 Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway. AZM, EM
2019 Diffuse panbronchiolitis: A progressive fatal lung disease that is curable with azithromycin, but only if diagnosed! ---
2019 Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides. BMI, P. aeruginosa
2019 The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis. CAM
2019 Yellow Nail Syndrome Patients with Diffuse Panbronchiolitis-like Pulmonary Manifestation. YNS
2018 Diffuse panbronchiolitis research in MEDLINE (1969-2017): Report of a bibliometric analysis. USA
2017 Coexistence of diffuse panbronchiolitis and asthma: reciprocity of neutrophilic and eosinophilic inflammation. ---
2017 Diffuse panbronchiolitis in a Samoan man. ---
2017 Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA). ATL, HABA, HTLV-1, IIP
10  2017 Successful treatment of diffuse panbronchiolitis in a child from Western China: A case report. ---
11  2016 Diffuse panbronchiolitis-The response and recurrence after erythromycin therapy. ---
12  2016 Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. CRS
13  2015 A case of diffuse panbronchiolitis, associated with severe pulmonary hypertension, managed with bilateral lung transplantation from a brain-dead donor. ---
14  2015 Hypereosinophilic obliterative bronchiolitis clinically mimicking diffuse panbronchiolitis: four-year follow-up. HOB
15  2015 Macrolides for diffuse panbronchiolitis. CBM, CI, CNKI, RCTs, RR
16  2015 Nontuberculous mycobacteria in diffuse panbronchiolitis. CF, NTM
17  2015 Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma. ---
18  2015 [Clinical Analysis of 35 Inpatients with Diffuse Panbronchiolitis in Peking Union Medical College Hospital]. ---
19  2014 Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? CVID
20  2014 Diffuse panbronchiolitis in an Australian aborigine. ---
21  2014 Primary ciliary dyskinesia complicated with diffuse panbronchiolitis: a case report and literature review. CT, PCD
22  2014 [A case of myasthenia gravis with invasive thymoma associated with diffuse panbronchiolitis, alopecia, dysgeusia, cholangitis and myositis]. CT, MG
23  2013 Clinical profiles of 12 Chinese patients with diffuse panbronchiolitis. ---
24  2013 Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients. ATLL, BAL, BALF, CT, FOXP3, HBZ, NSIP
25  2013 Long-term macrolide treatment for chronic respiratory disease. ---
26  2013 Lung miliary micro-nodules in human T-cell leukemia virus type I carriers. ATLL, HABA, HTLV-1, LIP
27  2013 Macrolides for diffuse panbronchiolitis. CBM, CI, CNKI, RCTs, RR
28  2013 The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases. HRCT
29  2012 A case of diffuse panbronchiolitis complicated by peripheral T cell lymphoma not otherwise specified. ---
30  2012 A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis. ---
31  2012 Differential association between HLA and diffuse panbronchiolitis in Northern and Southern Chinese. ---
32  2012 Diffuse panbronchiolitis. ---
33  2012 Evidence of improved small airways function after azithromycin treatment in diffuse panbronchiolitis. MBW
34  2012 Historical changes in epidemiology of diffuse panbronchiolitis. ---
35  2011 Carbamazepine-induced agammagloblinaemia clinically mimicking diffuse panbronchiolitis. CBZ
36  2011 Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases. ---
37  2011 Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis. HLA, SNP, VNTR
38  2010 Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy. Th2
39  2010 Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells. CF, HNP, IL, IPF
40  2010 Diffuse panbronchiolitis: report of a rare disease from India. ---
41  2010 Idiopathic bronchiolitis with features of diffuse panbronchiolitis in an African-American patient with hepatitis C virus infection. ---
42  2010 Low expression of T-cell co-stimulatory molecules in bone marrow-derived dendritic cells in a mouse model of chronic respiratory infection with Pseudomonas aeruginosa. DCs, IL, TNF
43  2010 Macrolides for diffuse panbronchiolitis. CBM, CENTRAL, CI, CNKI, RCTs, RR
44  2010 [Bronchiolitis with IgG4-positive plasma cell infiltration in a patient with bronchial asthma]. ---
45  2009 Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. CRS
46  2009 Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis. NTM
47  2008 Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. CF, COPD
48  2008 Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. CF, COPD
49  2008 Sarcoidosis in the setting of idiopathic chronic bronchiolitis with airway colonization from P. aeruginosa: treatment with low-dose macrolides. IB
50  2008 Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to macrolide therapy. VAS
51  2008 [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. HLA
52  2007 Association of HLA genes with diffuse panbronchiolitis in Chinese patients. ---
53  2007 Macrolide immunomodulation of chronic respiratory diseases. ---
54  2007 Prolongation of neutrophil survival by the culture supernatant of Pseudomonas aeruginosa. GM-CSF
55  2007 Serum levels of CA19-9 in patients with nonmalignant respiratory diseases. CDPF, IIP
56  2007 Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery? CF, sub-MIC
57  2007 [Diffuse panbronchiolitis in a child: case report and literature review]. HRCT
58  2006 Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. GVHD, OB
59  2006 Diffuse panbronchiolitis. ---
60  2006 The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis. ---
61  2005 Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. BPI-ANCA, CF, P. aeruginosa
62  2005 Childhood diffuse panbronchiolitis: a case report. ---
63  2005 Diffuse panbronchiolitis in China. ---
64  2005 Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. CAD, VC
65  2005 Neutrophil survival-enhancing activity in sputum from patients with diffuse panbronchiolitis. ---
66  2005 Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis. ---
67  2005 [A case of Kartagener's syndrome]. ---
68  2005 [Experimental study of an animal model of diffuse panbronchiolitis]. BALT, P. aeruginosa, SD
69  2004 A case of diffuse panbronchiolitis (DPB) in a patient positive for HTLV-1. ---
70  2004 Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. ---
71  2004 Clinical implications of the immunomodulatory effects of macrolides. IL
72  2004 Diffuse panbronchiolitis with histopathological confirmation among Chinese. ---
73  2004 Diffuse panbronchiolitis. ---
74  2004 Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. ERY
75  2004 Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. CF, MIC
76  2004 Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases. ---
77  2004 Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. CF
78  2004 Immunomodulatory effects of macrolides: implications for practicing clinicians. ---
79  2004 Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis. HTLV-I
80  2004 Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. AZM, CF
81  2004 Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. CF
82  2004 Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. GM-CSF, TNF
83  2004 Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. BALF, MBL
84  2004 Microscopic polyangiitis associated with diffuse panbronchiolitis. ---
85  2004 Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. CF
86  2004 Relation of epidermal growth factor receptor expression to mucus hypersecretion in diffuse panbronchiolitis. AB/PAS, EGFR
87  2004 The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis. BAL, EMC
88  2004 [Clinical study on development of nontuberculous mycobacterial lung disease]. CAM
89  2004 [Diffuse panbronchiolitis complicated by thymoma: a case report and a review of literature]. ---
90  2004 [Quorum sensing: the possibility of the new antibiotic target in bacterial infection]. ---
91  2003 Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. ---
92  2003 Diffuse panbronchiolitis in a Caucasian man in Canada. ---
93  2003 Diffuse panbronchiolitis. ---
94  2003 Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. AM, ERY
95  2003 High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. BAL, BOOP, ILD, NSIP, SP, UIP
96  2003 Idiopathic bronchiolitis mimicking diffuse panbronchiolitis. HRCT, IB
97  2003 Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. BAL, hBD
98  2003 Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. ---
99  2003 Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood. AZM, EM, RKM
100  2003 Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. CF, iNOS